Toward a Framework to Improve Diversity and Inclusion in Clinical Trials Proceedings of a Workshop (2025) / Chapter Skim
Currently Skimming:
Appendix B: Biographical Sketches of the Workshop Planning Committee and Speakers
Appendix B: Biographical Sketches of the Workshop Planning Committee and Speakers
Pages 83-104
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 83... ...
, is the former executive vice president and chief medical officer at Pfizer. Trained as a psychiatrist, she has held leadership roles in academia, medical research, frontline patient care, and global biopharmaceutical companies, including Vertex, Bristol Myers Squibb, and Eli Lilly.
|
From page 84... ...
SILAS BUCHANAN is the founder and CEO of the Institute for eHealth Equity, a social impact consulting firm. He is an experienced underserved community engagement strategist, dedicated to building equitable partnerships and crafting Web-based ecosystems that solve for known, outreach, and engagement failure points.
|
From page 85... ...
He is a fellow of the American College of C ardiology and American College of Physicians and past mem ber of the board of directors of the Founders Affiliate of the American Heart Association. He is a nationally and internationally recognized leader in cardiovascular education, clinical investigation, cardiovascular disease prevention, and health equity.
|
From page 86... ...
Kennedy School of Government. MARTIN MENDOZA, Ph.D., serves as the chief health equity officer at the Centers for Medicare & Medicaid Services (CMS)
|
From page 87... ...
and experiences to inform and conduct clinical and postmarket drug safety and effectiveness studies, including improving the quality and relevance of RWD (including data needed to advance health equity) , developing and advancing frameworks and tools to systematically describe data sources and methods for pre- and postmarket studies of product safety and effectiveness, and the Innovation in Medical Evidence, Development and Surveillance Program -- where such tools can be leveraged and tested for regulatory and nonregulatory studies.
|
From page 88... ...
; the chair of the National Cancer Policy Forum of the National Academies of Sciences, Engineering, and Medicine; a fellow of the American Associa tion for Cancer Research (AACR) A cademy; and a member of the board of directors for the American Cancer Society and LUNGevity Foundation.
|
From page 89... ...
Before Deloitte, Dr. Adam conducted her postdoctoral fellowship at Stanford University School of Medicine, where she was both an NIH and American Cancer Society supported fellow, and she earned her Ph.D.
|
From page 90... ...
She also is a past president and chair of the board of directors of the American Society of Clinical Oncology and has served on the board of directors of the American Cancer Society and the Prevent Cancer Foundation. In 2021, she was elected to the National Academy of Medicine, having served on its National Cancer Policy Forum.
|
From page 91... ...
He is a nationally recognized expert in cardiovascular medicine, health outcomes research, health care quality, and clinical research and a leader in the growing
|
From page 92... ...
He joined Alphabet in 2019, after serving as a professor of medicine and vice chancellor for clinical and translational research at Duke University. He also served as director of the Duke Translational Medicine Institute and was the founding director of the Duke Clinical Research Institute.
|
From page 93... ...
He has contributed to numerous health equity and health disparities articles and publications and been a guest lecturer at public and private organizations and numerous academic institutions. He serves on various local and national boards and committees focused on addressing barriers to health care and improving health outcomes, includ ing the Maryland Department of Health Advisory Committee on Minority Health, American Telemedicine Association Advisory Board on Eliminat ing Health Disparities, Health Care Payment Learning & Action Network Health E quity Advisory Team, Howard Community College Educational Foundation board, Johns Hopkins Howard County Medical Center Foun dation board, and Creating Healthier Communities board of directors.
|
From page 94... ...
It represents small and midsized companies and works to address concerns specific to this group of companies that comprise more than 70 percent of its overall membership. She also leads its health equity and women's health workstreams.
|
From page 95... ...
Her experience includes developing both qualitative and quantitative research methodologies that address each arm of the quintuple aim: equity, patient and provider experience, cost efficiency, and care quality. Before joining NACHC, she served as a consultant on hundreds of projects for government agencies at the federal, state, and local levels; she developed a sense for the importance of early stakeholder engagement, a deep understanding of the costs of health disparities, and a sense of purpose for improving health equity and access to care.
|
From page 96... ...
SHARI M LING, M.D., serves as the deputy chief medical officer for Centers for Medicare & Medicaid Services (CMS)
|
From page 97... ...
-funded, board-certified ophthalmologist, practicing vitreoretinal surgeon, and expert in health equity research and implementation science. She is the PI for the NIH-funded Sight-Saving E ngagement and Evaluation in New Haven Program, a multimethod approach to identifying and addressing health disparities in diabetic retinopathy.
|
From page 98... ...
National Advisory Council on Minority Health and Health Disparities. He is an active member in the AACR community and has served in several leadership capacities, such as on the steering com mittee for the inaugural Cancer Disparities Progress Report, the chair for Minorities in Cancer Research Council, conference cochair for the 11th Conference on Cancer Health Disparities, and cochair for the Think Tank on Cancer Health Disparities.
|
From page 99... ...
Dr. Rivers has endeavored to expand the application of population-based intervention/implementation/dissemination science to address cancer health disparities and advance cancer health equity in clinical and communitybased settings, using multilevel/multidomain/multisectoral approaches, such as novel technological platforms and iterations of the Patient Navigation model.
|
From page 100... ...
Dr. Rutter has earned a national and international reputation for her diverse and unique expertise via more than 50 publications in journals and received several scientific achievement awards, including a SmithKline Beecham Student Award in Pharmacology, Janssen Research Foundation Young Investigator Award, and National Cancer Institute (NCI)
|
From page 101... ...
from Georgetown University. VINDELL WASHINGTON, M.D., M.S., is the chief clinical officer and head of the Health Equity Center of Excellence at Verily; he leads clinical and data innovation teams across its care delivery and research solutions and also cross-functional teams focused on advancing health equity through its people and products.
|
From page 102... ...
Robert A Winn at the University of Illinois at Chicago Cancer Center and went on to become an independently funded researcher with funding from the National Cancer Institute, National Institute on Minority Health and Health Disparities, and National Heart, Lung, and Blood Institute.
|
From page 103... ...
The overall goal is to identify the spectrum of cancer-associated genomic mutations and mutational signatures in this understudied population, enhance access to state-of-the-art diagnostics and care, and drive cancer health equity.
|
From page 104... ...
at Mayo Medical School, now Mayo Clinic Alix School of Medicine, which included a medical student fellowship in immunology at NIH. She completed her residency and postdoctoral training in pathology and cancer research at Mayo Clinic, University of New Mexico, and University of Washington.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.